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Abstract
Background: There is increasing interest in improving the quality of care that patients with advanced dementia
receive when they are dying. Our understanding of the palliative care needs of these patients and the natural
history of advanced disease is limited. Many people with advanced dementia have unplanned emergency
admissions to the acute hospital; this is a critical event: half will die within 6 months. These patients have complex
needs but often lack capacity to express their wishes. Often carers are expected to make decisions. Advance care
planning discussions are rarely performed, despite potential benefits such more consistent supportive healthcare,
a reduction in emergency admissions to the acute hospital and better resolution of carer bereavement.
Design/Methods: We have used the MRC complex interventions framework, a "bottom-up" methodology, to
develop an intervention for patients with advanced dementia and their carers aiming to 1) define end of life care
needs for both patients and carers, 2) pilot a palliative care intervention and 3) produce a framework for advance
care planning for patients.
The results of qualitative phase 1 work, which involved interviews with carers, hospital and primary care staff from
a range of disciplines, have been used to identify key barriers and challenges. For the exploratory trial, 40 patients
will be recruited to each of the control and intervention groups. The intervention will be delivered by a nurse
specialist. We shall investigate and develop methodology for a phase 3 randomised controlled trial. For example
we shall explore the feasibility of randomisation, how best to optimise recruitment, decide on appropriate
outcomes and obtain data for power calculations. We will evaluate whether the intervention is pragmatic, feasible
and deliverable on acute hospital wards and test model fidelity and its acceptability to carers, patients and staff.
Discussion: Results of qualitative phase 1 work suggested that carers and staff were keen to discuss these issues
and guided the development of the intervention and choice of outcomes. This will be vital in moving to a phase
III trial that is pragmatic and feasible for these complex patients within the NHS
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Background
Dementia is a progressive neurodegenerative disease
which significantly reduces survival [1]. The admission to
hospital of a person with dementia with acute medical ill-
ness is a critical event: half will die within 6 months [2].
The end of life care received by this group is often poor [3]
and patients have inequitable access to palliative care serv-
ices [4].
Palliative care has been defined as "The active total care of
patients whose disease is not responsive to curative treat-
ment. Management of pain, other symptoms and psycho-
logical, social and spiritual problems is paramount. The
goal of palliative care is achievement of the best quality of
life for patients and their families" (WHO). The provision
of palliative care services, irrespective of diagnosis, has
been supported by a number of recent UK government
reports and policies including the 2005 Royal Commis-
sion Report [5], the National Audit Office and the End of
Life Care Improvement Programme.
Advance care planning discussions are a means by which
carers could plan for the future and feel more supported
in making decisions regarding patient care. Benefits may
include more consistent supportive care, fewer emergency
hospital admissions of patients with dementia and better
resolution of carer bereavement.
Design/Methods
Aims
Our aims are to improve the quality of end of life care
received by people with advanced dementia by interven-
ing at the point when patients have an unplanned admis-
sion to an acute general hospital.
Objectives
Our main objective is to assess the feasibility of imple-
menting a palliative care needs assessment and advanced
care plan for patients with advanced dementia who have
been admitted to the acute medical ward.
We will ascertain which outcome measures are the most
valid in this setting. We will also gather information on
recruitment, the feasibility of randomisation and attrition
in this cohort. We will obtain views from professionals
and patients on the acceptability and practicality of deliv-
ering or receiving the intervention and monitor the con-
sistency of its functional implementation.
Data will be used to generate the power calculation for a
definitive trial and will provide estimates of recruitment
rates, barriers to recruitment, the likely treatment effect
and reasons for attrition.
Developing complex interventions
This intervention has been designed using the MRC Com-
plex Interventions Framework [6]. This takes a phased
approach involving a series of steps from the pre-clinical
research phase (Phase 0) to the final phase IV when the
intervention is introduced in the NHS. This leads to the-
ory-driven interventions whose components are well
understood. This allows the "bottom up" development of
interventions, avoiding hastily embarking on complex
and expensive phase III trials that lack the appropriate the-
ory and pilot work.
Theoretical and pre-clinical work (phase 0)
We used a simple retrospective case note review method-
ology to demonstrate the poor quality of end of life care
that patients with advanced dementia receive when they
die on acute medical wards [3]. We then published a sys-
tematic review of the literature on palliative care interven-
tions for people with advanced dementia [7]. We found a
lack of adequately powered clinical trials in this field and
evidence that "palliative care" is often defined as a with-
drawal of treatment or of single interventions (i.e. "fever
management policies") rather than a holistic approach
that formulates a management plan according to individ-
ual needs of the patients and their families.
Modelling phase (phase 1)
Preliminary qualitative work
The principal carers of 20 patients with severe dementia,
Functional Assessment Staging (FAST) stage 6a and above
(difficulty dressing, bathing and using the toilet) [8]
admitted to the acute medical ward were recruited and
interviewed. Concurrently, 21 health care professionals
from a range of disciplines, care settings (acute hospital,
nursing home and primary care) and with varying degrees
of experience were interviewed. We used framework anal-
ysis to identify, extract and analyse core themes [9]. Carers
were keen to discuss these issues and it did not cause any
undue distress or concerns. In fact, most found the discus-
sion process very helpful.
Findings from qualitative work
Five main themes emerged from the data: illness aware-
ness, communication, pain awareness, attitudes towards
end of life treatments/quality of life and hospitalisation.
Illness awareness
Families were aware that their relative's memory problems
would deteriorate but were often unaware of disease pro-
gression and the terminal nature of dementia. This lack of
understanding was also found in health care profession-
als, especially junior members of staff. Many did not
attribute physical deterioration to dementia.BMC Palliative Care 2008, 7:8 http://www.biomedcentral.com/1472-684X/7/8
Page 3 of 9
(page number not for citation purposes)
Communication
The provision of information by health care professionals
to relatives/carers was mixed. Hospital doctors tended to
give information to families regarding the patient's imme-
diate health status while primary care physicians appeared
to rely on secondary care to provide relatives with infor-
mation. A majority of relatives said they wanted more
information about the symptoms of advanced dementia,
treatment options and planning ahead. A small minority
found it distressing to discuss the patient's future. Both
professionals and carers were concerned by inadequate
communication between primary and secondary care,
especially during hospital admission.
Pain awareness
Most participants, relatives and healthcare professionals
felt confident in recognising pain in patients with demen-
tia although some admitted it was sometimes a "guessing
game". Doctors often relied on relatives and nursing staff
to guide them. However, the majority of relatives did not
think their care recipient was in pain despite many suffer-
ing from pressure sores, arthritis and urinary tract infec-
tions. Residents in nursing homes commonly had to wait
for the GP to assess them which suggests a delay in the
provision of adequate pain control. No one mentioned
the use of pain assessment tools.
Attitudes towards end of life treatments and quality of life
All physicians thought resuscitating patients with
advanced dementia was unacceptable. Relatives' views
were, however, mixed and mainly depended on religious
beliefs, patients' wishes, patients' quality of life or what
relatives would want for themselves in similar circum-
stances. Some felt very worried about the emotional con-
sequences of making such decisions. Attitudes towards
feeding tubes also varied between heath care professionals
and relatives. Every participant with one exception agreed
that patients should always be treated with antibiotics for
pneumonia/chest infections.
Hospitalisation
Decisions on admitting patients to hospital were influ-
enced by a lack of understanding of dementia as a neuro-
degenerative illness. Most hospital staff commonly
believed that care could be provided equally well in the
home or nursing home albeit acknowledging that com-
munity services might be reluctant to take responsibility.
Nursing home staff felt they must send patients to hospi-
tal in response to requests from the GP or the family.
Often, relatives favoured hospitalisations initially but
later regretted their decision as it became apparent that
hospital staff had less time to devote to patient care.
To conclude, a lack of understanding of the natural his-
tory of dementia emerged as one major barrier to improv-
ing end of life care for patients with advanced dementia.
It served to influence attitudes towards treatments and
end of life care decisions. This suggests that communica-
tion should be at the centre of an intervention attempting
to improve end of life care for this patient group, espe-
cially providing relatives with adequate information
regarding the nature of dementia and its likely progres-
sion.
Exploratory trial (phase 2)
The qualitative data arising from the phase I study have
been used to design an intervention for patients and carers
that ensures adequate assessment and delivery of pallia-
tive care to patients with advanced dementia and includes
a framework for discussing advance care planning. This
study aims to pilot the intervention in a phase II explora-
tory/feasibility trial.
Study setting
The study is set on acute medical wards for people over the
age of 70 years in the Royal Free Hospital NHS Trust, a
large inner London teaching hospital serving an inner city
population that is diverse in terms of socioeconomic and
ethnic mix.
Inclusion criteria
These are intentionally broad to ensure that the patients
are representative of this population. We will recruit
patients with advanced primary degenerative dementia
(FAST stage 6a or worse; problems dressing, urinary
incontinence and needing assistance with all activities of
daily living) who have a high 6-month mortality risk [10].
They will be over 70 years of age with unplanned emer-
gency admissions for treatable acute medical illness. Their
carers will be defined as family members or friends who
are in regular contact with the patient and who do not act
in any professional capacity. They must be next of kin or
"key decision makers" and willing to undergo assessment
of their own needs and health
Exclusion criteria
We will exclude patients without a clearly identified non-
statutory carer. Carers should be able to communicate in
English to a degree whereby they can participate in the
interviews and assessments (unfortunately limited fund-
ing precludes the provision of interpreters). We will also
need to exclude carers who do not have full mental capac-
ity to give consent to participate in research.
Patient recruitment
The research team will screen all admissions to two acute
wards (intervention and control) and identify potential
participants. We will monitor recruitment rates per month
in relation to the total numbers of patient/carer dyads
who would be eligible and detail reasons for those whoBMC Palliative Care 2008, 7:8 http://www.biomedcentral.com/1472-684X/7/8
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decline to participate. We intend to recruit 40 patients and
carers to the intervention arm and 40 patients and carers
to the control arm. For an overview of measurements
taken during the study, see Table 1.
Intervention
Feedback and refinement of pilot intervention
Because the intervention is based on the fundamental
principles of palliative care, it will remain relatively con-
stant. We will, however, test alternative formats  of the
intervention in order to obtain the most pragmatic and
clear version. The intervention will be piloted on 5
patients and their carers. A chartered health psychologist,
employed for the whole study, collected the phase 1 qual-
itative data. She will obtain informal feedback from carers
and key staff in the medical multi-disciplinary team
(MDT). The next version will be piloted on a further 5
patients and their carers and modified in accordance with
findings until a final format is reached.
During the pilot trial, we shall seek practitioners' and car-
ers' views of the intervention by using semi-structured
interviews. These data will be used iteratively to optimise
implementation of the intervention. We shall assess
whether carers and professionals regard the intervention
as coherent, understandable, acceptable and potentially
integral to the service. We shall also examine change man-
agement and the factors that make implementation diffi-
cult in each setting [11]. If necessary, we will seek
permission from the ethics committee to make substantial
amendments to the protocol.
Study procedures-Control arm
The patients and carers in the control arm will be recruited
from an adjacent ward. They will be fully informed about
the trial but there will be no change to usual care. Identical
outcome measures will be used for both control and inter-
vention groups. If the trial reveals areas of clinical need
Table 1: Study schedule
Measure Source Baseline 6 weeks 6 months Subsequent 
hospital admission
Time of death 3 months post 
bereavement
Carer related
KD-10 Carer xx x x
Satisfaction with end 
of life care in 
dementia scale
Carer x
Decision satisfaction 
inventory
Carer xx x
EQ 5D Carer xx x x
Visual analogue scale Carer xx x x
Economic data Carer xx
Patient related
Pain scale 
measurements
Patient
Painful interventions 
scale
Patient care records xx x
Other interventions Patient care records xx x
Quality of end of life 
care
Patient care records xx
Adherence to LCP Patient care records xx
System related
Numbers choosing 
to make ACP
Patient care records xx
Adherence to 
advance care plan
Patient care records x
Referrals to palliative 
care team
Patient care records xx x
Unplanned 
admissions
Patient care records xx x
Place of death Patient care records x
Economic data Patient care records xx xBMC Palliative Care 2008, 7:8 http://www.biomedcentral.com/1472-684X/7/8
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the MDT will be informed and this intervention docu-
mented.
Study procedures-Intervention arm
The intervention will be delivered by a clinical research
nurse experienced in the care of patients with dementia
and acute medical illness and dealing with discussions of
a sensitive nature who has received training in specialist
palliative care. The nurse will assess the patients and carry
out the discussion and advanced care planning with the
carers. She will liaise with the clinical team and others
involved in the patients' care, for example the GP or nurs-
ing home. In addition patients and carers in this arm will
receive standard hospital treatment.
Stage 1: Assessment of patient
Most elements of the patient assessment could be consid-
ered routine clinical care. However, we aim to formalise
and integrate this information into a more specialised
evaluation. The assessment will also inform the discus-
sion with the carer. The holistic assessment will take
approximately 30 minutes and will cover a range of
domains including dementia severity, the presence of
delirium, communication, pressure sores and skin condi-
tion, food and fluid intake, swallowing and feeding (see
Table 2).
The measurement of pain in people with dementia is dif-
ficult. We aim to measure both the severity and number of
pain symptoms present. There are no dementia pain scales
validated for use in an acute hospital setting. We will, as
part of this pilot study, evaluate a range of pain scales in
acutely unwell patients with dementia. The scales are sim-
ple and require only concurrent observation of the patient
or the opinion of current caregivers and staff.
This will generate a list of the patient's active problems
that will be discussed with the clinical team. A manage-
ment plan will be formulated and will be documented in
the clinical notes. If patients are identified as being in the
terminal phase (last 48 hours of life), this will be dis-
cussed urgently with the clinical team who may decide
that the patient should be transferred to Liverpool Care
Pathway [12].
Stage 2: Assessment and discussion with carer
This will take the form of up to two structured consulta-
tions (at least 5 days apart) and based on principles
underpinning palliative care (physical, social, psycholog-
ical, spiritual, cultural, information) and on the findings
of the qualitative phase. This discussion will be initiated
on the acute medical ward but if the patient is discharged
will be completed in the community.
In the first consultation, we will obtain a baseline under-
standing of the current situation and context of both
patient and carer and carry out an assessment of needs.
We will assess the carer's level of knowledge about the
patient's dementia, level of severity and prognosis, and
Table 2: Patient assessment
Dementia Severity
Functional Assessment Staging (FAST) Score [8]
An observational scale describing a continuum of 7 successive stages 
from normal to the most severe dementia
Delirium
Confusion Assessment Measure (CAM) [18]
The most widely used instrument for the detection of delirium. It has a 
sensitivity of 94–100% and a specificity of 90–95%.
Pain and discomfort
Abbey Pain Scale [19]. A brief 6-item scale to measure the intensity/severity of acute and 
chronic pain in late stage dementia
Pain Assessment Checklist for Seniors with Severe Dementia (PACSLAC) 
[20]
Measures the number of pain symptoms present
Doloplus-2 [21] A 10-item observational scale for use in non-verbal adults. Addresses a 
wide range of pain indicators
Communication Clinical assessment of patient's ability to communicate their needs 
including non-verbal communication and comprehension.
Pressure sores and skin condition
Waterlow Scale [22]
Stirling Scale [23]
The Waterlow scale is routinely used for the assessment of risk for 
developing pressure sores.
The Stirling Scale measures the extent of damage from 1, Non-blanching 
erythema of intact skin to 4, full-thickness wound, which involving 
subcutaneous tissue and the deep fascia.
Mobility Is the patient bed bound/able to turn themselves? Can they walk with/
without use of aids i.e. Zimmer frame?
Elimination Continence is routinely assessed as part of the FAST scale. Patients will 
also be assessed for the presence of urinary tract infection and 
constipation.
Food and fluid intake As routinely documented on food and fluid chart
Swallowing and feeding Formal assessment by speech and language therapy will be requested if 
there is clinical suspicion of difficulty.BMC Palliative Care 2008, 7:8 http://www.biomedcentral.com/1472-684X/7/8
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ask them to identify the patient's physical needs of most
concern to them.
The social situation will be evaluated in terms of family
dynamics and defining the key decision makers regarding
the person's care, the current level of support, date of most
recent needs assessment from social services, and carer's
unmet health, social and financial needs. We will assess
the level of psychological support that the carer has avail-
able to them and spiritual and cultural factors such as the
faith background of both patient and carer. We will assess
the  information  available such as whether the person
with dementia made any previous advanced directives or
expressed any opinions in the past, for example, preferred
place of care at time of death.
The discussion will be concluded by summarising and
acknowledging the carer's role and the main issues dis-
cussed. This will be documented using a standardised
form. Any issues of serious concern will be discussed with
the medical multidisciplinary team and this intervention
documented.
In the second consultation we will provide and discuss
information. This will take account of, and respect, the
patient and carer's individual circumstances established in
the first interview. We shall start by giving basic education
on dementia as a neurodegenerative disease and provide
carers with information on the prognosis of advanced
dementia, palliative care (focusing on palliative care as
appropriate active care and management, NOT with-
drawal of treatment) and advanced care planning. Carers
will then be given the opportunity to make an advanced
care plan for the patient if they wish to do so.
The advanced care planning phase of the intervention was
developed using the phase I qualitative work and a
number of current UK Department of Health guidelines.
Advance Care Planning (ACP) has been defined as a proc-
ess of discussion between an individual and their care pro-
viders. This includes important values or personal goals
for care, understanding about illness and prognosis and
preferences for types of care or treatment that may be ben-
eficial in the future and the availability of these [13]. We
will pilot an adapted version of a tool developed by the
UK National Health Service (Preferred Priorities for Care)
[14]. We will use this tool to address specific issues iden-
tified by the patient assessment and the initial carer dis-
cussions.
Care planning involves the discussion of sensitive and
potentially upsetting issues and carers may require ongo-
ing support and advocacy for further decision making.
Whether or not the carer decides to make an advance care
plan, the nurse will end the process by signposting or
facilitating referral to services so that unmet patient and
carer needs can be addressed. Carers will be given a con-
tact card for the research nurse. The advanced care plan
with statement of preference and wishes will be written up
and if the carer consents, copies will be placed in the med-
ical notes, sent to the GP (and if relevant the nursing
home) and kept by the carer.
Outcome measures
This is a pilot study, so we will examine the feasibility of
a number of outcome measures to identify those with
most utility for a future phase III randomised controlled
trial. Four main domains of outcomes will be assessed
(Table 3).
1) Carer related – such as stress and well being, general
health and quality of life, satisfaction with the decision
making process and a general measure of how they expe-
rienced the care planning process.
2) Patient related – to include measures of painful medical
interventions i.e. intravenous cannulation, measurement
of arterial blood gases), indicators of the quality of end of
life care and survival time (intervention until death).
These do not involve any burden to the patient and are
gathered from routine clinical documentation.
3) System-related – for example adherence to the advanced
care plan, referrals to and input from community pallia-
tive care, rates of unplanned hospital admission, and
place of death.
4) Economic measures – differences between intervention
and control groups may have an economic impact (posi-
tive or negative) in terms of health/social care resources
used and also help provided by informal carers. Data on
hospital stays will be obtained from administrative
records.
Follow-up
The timing of patient and carer follow up assessments has
been determined by the published evidence on survival
time and prognosis for these patients (see Table 1). We
will assess the feasibility of long term follow up i.e.
whether reliable data can be collected about the care
received at death. We will follow up patients and carers at
6 weeks from the index admission, at any subsequent hos-
pital admissions and at 6 months from baseline. We aim
to interview carers again three months after bereavement.
Data management and analysis
We shall use descriptive statistics to examine baseline data
on proportions of carers agreeing to assessment and
patients' demographic and clinical characteristics. Follow-
up rates will be reported. Outcome measures, includingBMC Palliative Care 2008, 7:8 http://www.biomedcentral.com/1472-684X/7/8
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clinical and health economic outcomes will be explored
using descriptive statistics. Differences between the inter-
vention and control groups will be investigated using
regression methods to control for baseline characteristics.
We will estimate the likely effect size of the intervention
(additional to usual care) in order to guide a sample size
calculation for a definitive phase III randomised trial. Eco-
nomic factors will also be evaluated; unit costs [15] will be
estimated for each of the study arms and the cost for each
patient calculated. These will be linked to the short-term
outcomes in the form of an incremental cost-effectiveness
analysis that will enable us to make preliminary compari-
sons between the intervention and control groups in
terms of the cost of achieving unit changes in outcomes.
Cost comparisons between the two arms will be made
using bootstrapping methods if data are skewed.
Ethical issues
By definition, this research will be carried out on subjects
who are unable to give informed consent. Our study was
approved by the ethics committee of Camden and Isling-
ton Mental Health and Social Care Trust (London, UK).
This ethics committee is "flagged" to consider research on
those unable to consent for themselves, as described in
Section 30 of the Mental Capacity Act 2005. We believe
that the risk to patients and carers is negligible and this
project does not involve any invasive procedures. We will
consult and seek assent from the carers and any other rel-
evant people as defined by section 32 of the Mental
Capacity Act (2005) code of practice. As we will be meas-
uring the impact of the intervention on specific carer out-
comes we will seek fully informed consent from the carer
for their own participation as a subject.
Discussion
Patients with advanced dementia have complex physical
and psychological needs. They are different to many other
terminally ill patients in that they have severe impairment
of basic activities of daily living and may lack capacity to
make appropriate decisions regarding their choices and
preferences at the end of life. Assessing needs at the end of
life and planning care is a complex issue and, in people
with advanced dementia, much of this may be done by
proxies. These difficulties are further increased by the
healthcare system. People with advanced dementia may
reside in nursing homes and at the same time be under the
Table 3: Study outcome measures
Carer
Stress and wellbeing
Kessler Distress Scale (KD10) [24]
10-item scale, validated and widely used screening tool for psychological 
distress. It is discriminative in detecting "caseness" for DSM-IV disorders
Health Status
(EQ-5D) [25].
Standardised, short, 5-item scale instrument for health and quality of life
Decision-making process
Decision Satisfaction Inventory [26]
Validated measure with three sub-scales measuring overall satisfaction 
with medical care, satisfaction with the decision making process, and 
satisfaction with the decisions made
Satisfaction with decision-making process-Decision Conflicts Scale Validated, 16-item scale measures uncertainly and difficulties in the 
decision making process [27].
Satisfaction with care
Satisfaction with End of Life Care in Advanced Dementia Scale [28]
Specifically developed for use in advanced/end stage dementia. Three 
separate domains of measurement; satisfaction with the terminal care, 
symptom management, comfort during the last 7 days of life. Only to be 
completed after the patient has died.
Visual analogue scales A standard 10 cm visual analogue scale to measure carers satisfaction with:
1) the process of the advanced care planning
2) the utility/usefulness of the advance care planning
Patient
Active interventions
Painful Interventions Scale [29]
Measures invasive hospital procedures shown to be moderately to 
severely painful or uncomfortable including arterial blood gas testing, 
mechanical ventilation, naso-gastric feeding and bladder catheterisation
Other interventions i.e. Resuscitation status, PEG feeding, prescription of neuroleptics
Quality of end of life care Prescription of analgesia at time of death, use of Liverpool Care Pathway
Survival times Time of intervention to time of death
System
Advanced care planning Numbers choosing to make advanced care plan and adherence to advance 
care plan
Readmission rates For emergency acute admissions
Place of death
Referrals To community palliative care
Economic
Service use costs [30]
Client Service Receipt Inventory (CSRI)
Baseline, 6 months and, if relevant, for the month prior to deathBMC Palliative Care 2008, 7:8 http://www.biomedcentral.com/1472-684X/7/8
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care of acute hospitals, community mental health teams
and clinical staff from a range of specialities spanning pri-
mary and secondary care. This complicated care system
makes adequate communication between care providers,
patients and their carers very challenging.
We have used the MRC complex interventions framework
to move from our earlier theoretical work to pilot an inter-
vention that aims to address the issues described above.
The findings from the qualitative phase were vital in
investigating and teasing out the important "ingredients"
of an intervention. It highlighted challenges to improving
end of life care for this patient group. In particular, it dem-
onstrated a widespread lack of understanding of the natu-
ral history of dementia and its progression. This suggests
that education and advanced care planning discussions
should be at the centre of an intervention. Benefits may
extend to improved understanding, more appropriate
decision making and thereby reductions in un-necessary
hospitalisations as well as more appropriate end of life
care for patients with advanced dementia. It may also lead
to greater satisfaction with end of life care and better
bereavement outcomes in relatives.
We shall use this pilot phase to evaluate whether the inter-
vention is pragmatic and feasible within the challenging
environment of NHS acute hospital wards. It will be ena-
ble us to determine which are the most effective and use-
ful outcome measures and what may be the best measures
of effectiveness; these may differ between the carer, poten-
tial benefit for the person with dementia and wider bene-
fit to the health service. We do not know which aspect of
the intervention will provide the active component that
most influences change within this complex system. We
envisage that to avoid "contamination" the future phase
III trial will be clustered at hospital ward level. By defining
key primary outcomes we will be able to generate data for
a power calculation, which is vital as we anticipate that
cluster randomisation will be the optimal methodology.
The preparatory work allowed us to explore ethical issues
regarding research on subjects who do not have the capac-
ity to give fully informed consent to participate. We used
an ethics committee "flagged" to deal with research on
subjects who lack the capacity to consent (under the terms
of the recently enacted Mental Capacity Act) and will gain
assent from their carers. We believe that this research
brings a number of potential benefits as determined by
the Act, for example "developing more effective ways of
treating a person or managing their condition", "improv-
ing the quality of healthcare, social care or other services
that they have access to" and "reducing the risk of the per-
son being harmed, excluded or disadvantaged".
There are a number of methodological issues that still
require consideration. We do not know what constitutes a
good outcome in these patients with advanced dementia
who are generally unable to express their needs and
wishes. We will use the views of proxies which may not
accurately reflect patients' wishes when they last had
capacity.
It could be argued that much of what comprises this inter-
vention is just good quality care and should be part of rou-
tine clinical practice; it is too much like what professionals
believe they "do already". Naturally, some elements of the
intervention will occur in usual care, although all the evi-
dence published to date suggests that it is rarely carried
out in a consistent manner. Furthermore, this sort of con-
cern hardly ever interferes with a careful, controlled eval-
uation [16]. In addition to evaluating the intervention
itself, we will also assess its implementation in terms of
change management within a complex health [17] sys-
tem.
The results of our study may have wider implications, par-
ticularly with regards to palliative care interventions in
neurodegenerative disease and conditions other than can-
cer where patients may lack capacity and the disease tra-
jectory is not easy to predict.
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